SCI Abstract

search
+
Validation of CTS5 Model in Large-scale Breast Cancer Population and Combination of CTS5 and Ki-67 Status to Develop a Novel Nomogram for Prognosis Prediction
Validation of CTS5 Model in Large-scale Breast Cancer Population and Combination of CTS5 and Ki-67 Status to Develop a Novel Nomogram for Prognosis Prediction
Background: More than half of patients with early-stage estrogen receptor-positive (ER+) breast c
ACR–ARS Practice Parameter for Communication: Radiation Oncology
ACR–ARS Practice Parameter for Communication: Radiation Oncology
Background: This practice parameter was revised collaboratively by the American College of Radiol
Impact of Maximum Point Dose Within the Planning Target Volume on Local Control of Nonsmall Cell Lung Cancer Treated With Stereotactic Body Radiotherapy
Impact of Maximum Point Dose Within the Planning Target Volume on Local Control of Nonsmall Cell Lung Cancer Treated With Stereotactic Body Radiotherapy
Background: No consensus exists on the maximum dose delivered to the planning target volume (PTV)
ACR–ARS Practice Parameter for Radiation Oncology
ACR–ARS Practice Parameter for Radiation Oncology
Background: This practice parameter was revised collaboratively by the American College of Radiol
Microbiome and Abdominopelvic Radiotherapy Related Chronic Enteritis: A Microbiome-based Mechanistic Role of Probiotics and Antibiotics
Microbiome and Abdominopelvic Radiotherapy Related Chronic Enteritis: A Microbiome-based Mechanistic Role of Probiotics and Antibiotics
Chronic diarrhea and abdominal pain after radiotherapy continue to be a problem in cancer survivors.
Feasibility, Tolerability, and Effectiveness of Transbronchial Interventions in Elderly Patients With Malignant Central Airway Obstruction: A Retrospective Single-institution Study
Feasibility, Tolerability, and Effectiveness of Transbronchial Interventions in Elderly Patients With Malignant Central Airway Obstruction: A Retrospective Single-institution Study
Background: In elderly patients with malignant central airway obstruction (MCAO), the treating ph
Disparities in the Receipt of Systemic Treatment in Metastatic Melanoma
Disparities in the Receipt of Systemic Treatment in Metastatic Melanoma
Background: In 2011, immunotherapy and targeted therapy revolutionized melanoma treatment. Howeve
Recurrence Risk Stratification for Women With FIGO Stage I Uterine Endometrioid Carcinoma Who Underwent Surgical Lymph Node Evaluation
Recurrence Risk Stratification for Women With FIGO Stage I Uterine Endometrioid Carcinoma Who Underwent Surgical Lymph Node Evaluation
Objective: The aim of this study was to estimate the recurrence risk based on the number of progn
The Prognostic and Functional Impact of Sprouty 2 Expression in Non–small Cell Lung Cancer
The Prognostic and Functional Impact of Sprouty 2 Expression in Non–small Cell Lung Cancer
Objective: We represent Sprouty 2 (Spry2) expression analysis and its association with key driver
MRI-guided Real-time Online Gated Stereotactic Body Radiation Therapy for Liver Tumors
MRI-guided Real-time Online Gated Stereotactic Body Radiation Therapy for Liver Tumors
Background: Liver tumors are commonly encountered in oncology. The study aimed to assess the impa
Metaplastic Breast Carcinoma: Clinicopathologic Features and Recurrence Score Results From a Population-based Database
Metaplastic Breast Carcinoma: Clinicopathologic Features and Recurrence Score Results From a Population-based Database
Objectives: Metaplastic breast carcinoma (MBC) is a rare, aggressive form of cancer comprising ep
Secondary Breast Angiosarcoma After a Primary Diagnosis of Breast Cancer: A Retrospective Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database
Secondary Breast Angiosarcoma After a Primary Diagnosis of Breast Cancer: A Retrospective Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database
Objectives: Angiosarcoma is a rare complication of breast-conserving therapy. This study evaluate
A Meta-analysis of Randomised Controlled Trials Comparing Combination Therapy as Second-line Treatment With Monotherapy in Advanced Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutation
A Meta-analysis of Randomised Controlled Trials Comparing Combination Therapy as Second-line Treatment With Monotherapy in Advanced Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutation
Background: Epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors are standard thera
Genomic and Molecular Characteristics of Ovarian Carcinosarcoma
Genomic and Molecular Characteristics of Ovarian Carcinosarcoma
Ovarian carcinosarcoma (OCS) is a rare malignancy with a poor prognosis. It is a biphasic tumor with
Does the Shift Away From Frame-based Stereotactic Radiosurgery Endanger Radiation Oncology’s Seat at the Table in Treating Functional Disorders?
Does the Shift Away From Frame-based Stereotactic Radiosurgery Endanger Radiation Oncology’s Seat at the Table in Treating Functional Disorders?
Departments of Radiation Oncology and Neurological Surgery, University Hospitals Seidman Cancer Center Case Western...
Prognostics of Systemic Malignancy ICD-O Topography and Morphology Types on Brain Metastases: An NCDB Time-to-event Cohort
Prognostics of Systemic Malignancy ICD-O Topography and Morphology Types on Brain Metastases: An NCDB Time-to-event Cohort
Background: The primary site and histology of systemic malignancy are known predictors of progres
Differentiating Radiation Necrosis and Metastatic Progression in Brain Tumors Using Radiomics and Machine Learning
Differentiating Radiation Necrosis and Metastatic Progression in Brain Tumors Using Radiomics and Machine Learning
Objectives: Distinguishing between radiation necrosis (RN) and metastatic progression is extremel
Correlation of Lung Immune Prognostic Index With Efficacy of PD-1/PD-L1 Inhibitor Combined With Chemotherapy and Prognosis in Patients With Advanced Non–Small Cell Lung Cancer
Correlation of Lung Immune Prognostic Index With Efficacy of PD-1/PD-L1 Inhibitor Combined With Chemotherapy and Prognosis in Patients With Advanced Non–Small Cell Lung Cancer
Objective: Non–small cell lung cancer (NSCLC) is a devastating but universal class of lung carcin
Geographic Disparities in Access to Cancer Clinical Trials in Canada
Geographic Disparities in Access to Cancer Clinical Trials in Canada
Objective: This study aims to evaluate geographic disparities in access to cancer clinical trials
Pathologic Nodal Staging Before SBRT for Early-stage NSCLC Does Not Impact Overall Survival: A Propensity Score–matched NCDB Analysis
Pathologic Nodal Staging Before SBRT for Early-stage NSCLC Does Not Impact Overall Survival: A Propensity Score–matched NCDB Analysis
Objective: Stereotactic body radiation therapy (SBRT) for early-stage non–small cell carcinoma of
Neoadjuvant Immunotherapy and Non–Small Cell Lung Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Neoadjuvant Immunotherapy and Non–Small Cell Lung Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Objectives: To systematically evaluate the effectiveness and safety of neoadjuvant immunotherapy
Comparison of Tumor Bed Delineation Using a Novel Radiopaque Filament Marker Versus Surgical Clips for Targeting Breast Cancer Radiotherapy
Comparison of Tumor Bed Delineation Using a Novel Radiopaque Filament Marker Versus Surgical Clips for Targeting Breast Cancer Radiotherapy
Background: Accuracy of tumor bed (TB) delineation is essential for targeting boost doses or part
Treatment of Cancer Pain: A Systematic Review
Treatment of Cancer Pain: A Systematic Review
Contextualization: One of the biggest problems regarding the treatment of cancer patients is pain
Clinical Outcomes of First-line Therapies for Advanced Non–Small Cell Lung Cancer: A Systematic Review of Trials Published Between 2010 and 2020
Clinical Outcomes of First-line Therapies for Advanced Non–Small Cell Lung Cancer: A Systematic Review of Trials Published Between 2010 and 2020
Objectives: To analyze the evolution of clinical outcomes derived from clinical trials on first-l
The Prognostic Significance of the Depth of Cervical Stromal Invasion in Women With FIGO Stage II Uterine Endometrioid Carcinoma
The Prognostic Significance of the Depth of Cervical Stromal Invasion in Women With FIGO Stage II Uterine Endometrioid Carcinoma
Objective: The objective of this study was to investigate the prognostic significance of the dept
The Application of Nano-drug Delivery System With Sequential Drug Release Strategies in Cancer Therapy
The Application of Nano-drug Delivery System With Sequential Drug Release Strategies in Cancer Therapy
Currently, multidrug combinations are often used clinically to improve the efficacy of oncology chem
Management Strategies and Outcomes in Primary Liver Angiosarcoma
Management Strategies and Outcomes in Primary Liver Angiosarcoma
Objectives: Primary hepatic angiosarcoma is a rare tumor of the liver that originates from endoth
Effect of Frailty on Hospital Outcomes Among Pediatric Cancer Patients in the United States: Results From the National Inpatient Sample
Effect of Frailty on Hospital Outcomes Among Pediatric Cancer Patients in the United States: Results From the National Inpatient Sample
Background: Studies on frailty among pediatric patients with cancer are scarce. In this study, we
Decision-making for Subsequent Therapy for Patients With Recurrent or Advanced Endometrial Cancer Based on the Platinum-free Interval
Decision-making for Subsequent Therapy for Patients With Recurrent or Advanced Endometrial Cancer Based on the Platinum-free Interval
Objective: The aim of this study was to evaluate the progression-free survival (PFS) and overall
PARP Inhibitors in Newly Diagnosed and Recurrent Ovarian Cancer
PARP Inhibitors in Newly Diagnosed and Recurrent Ovarian Cancer
Ovarian cancer is the most lethal gynecologic malignancy, characterized by a high death-to-incidence
Load More
format_indent_increase